| Literature DB >> 26193370 |
Hung-Yang Chang1, Yi-Hsiang Sung2, Shwu-Meei Wang3, Hou-Ling Lung2, Jui-Hsing Chang3, Chyong-Hsin Hsu3, Wai-Tim Jim3, Ching-Hsiao Lee4, Hsiao-Fang Hung4.
Abstract
BACKGROUND: Neonatal hypothermia remains a common problem and is related to elevated morbidities and mortality. However, the long-term neurodevelopmental effects of admission hypothermia are still unknown. This study attempted to determine the short-term and long-term consequences of admission hypothermia in VLBW preterm infants. STUDYEntities:
Mesh:
Year: 2015 PMID: 26193370 PMCID: PMC4507863 DOI: 10.1371/journal.pone.0131976
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Temperature at admission to NICU (degrees centigrade).
Comparison of maternal and infant variables among groups.
| Normothermia (N = 79) | Mild hypothermia | Moderate hypothermia (N = 162) |
| |
|---|---|---|---|---|
| Birth weight, mean ± SD (g) | 1187 ± 269 | 1142 ± 250 | 1004 ± 301 | < 0.001 |
| Gestational age, mean ± SD (wk) | 29.7 ± 3.1 | 29.5 ± 3.0 | 28.1 ± 3.2 | < 0.02 |
| SGA | 26 (33%) | 40 (40%) | 61 (38%) | 0.62 |
| Male | 40 (51%) | 58 (58%) | 84 (52%) | 0.54 |
| Cesarean section | 52 (66%) | 74 (74%) | 117 (72%) | 0.44 |
| Antenatal steroids | 65 (82%) | 85 (85%) | 130 (80%) | 0.60 |
| PROM > 18 h | 36 (46%) | 37 (37%) | 53 (33%) | 0.15 |
| 1-min Apgar Score < 7 | 25 (32%) | 40 (40%) | 103 (64%) | < 0.001 |
| 5-min Apgar Score < 7 | 6 (8%) | 13 (13%) | 29 (18%) | 0.09 |
| Resuscitation | 11 (14%) | 20 (20%) | 45 (28%) | 0.99 |
| Acidosis (pH < 7.2) | 10 (13%) | 26 (26%) | 63 (39%) | 0.43 |
PROM, premature rupture of membrane; SGA, small for gestational age.
aNo statistically significant P value: mild hypothermia group compared to normothermia group.
b P value: moderate hypothermia group compared to normothermia group.
Short-term outcomes between groups.
| Normothermia (N = 79) | Mild hypothermia | Moderate hypothermia (N = 162) |
| Adjusted | ||
|---|---|---|---|---|---|---|
| OR (95% CI) | P value | |||||
| RDS required surfactant | 31 (39.2%) | 47 (47.0%) | 94 (58.0%) | 0.006 | 2.66 (1.27–5.58) | 0.009 |
| IVH grade III–IV | 2 (2.5%) | 3 (3.0%) | 8 (4.9%) | 0.56 | 1.31 (0.33–5.27) | 0.43 |
| NEC ≥ Stage II | 0 (0%) | 1 (1.0%) | 4 (2.5%) | 0.29 | 3.56 (0.30–41.78) | 0.35 |
| Late-onset sepsis | 12 (15.2%) | 10 (10.0%) | 27 (16.7%) | 0.54 | 0.85 (0.35–2.04) | 0.32 |
| PDA required treatment | 21 (26.6%) | 29 (29.0%) | 37 (22.8%) | 0.49 | 0.76(0.33–1.320) | 0.24 |
| ROP required therapy | 5 (6.6%) | 7 (7.9%) | 13 (9.8%) | 0.63 | 0.85 (0.29–2.43) | 0.51 |
| Oxygen at 36 wk | 23 (30.7%) | 24 (27.0%) | 43 (32.6%) | 0.81 | 0.83 (0.38–1.82) | 0.65 |
| cPVL | 1 (1.3%) | 2/89 (2.2%) | 5 (3.8%) | 0.42 | 5.44 (0.43–69.62) | 0.19 |
| Mortality | 4 (5.1%) | 11 (11.0%) | 30 (18.5%) | 0.005 | 2.83 (0.85–8.38) | 0.04 |
cPVL, cystic periventricular leukomalacia; IVH, intraventricular hemorrhage; NEC, necrotizing enterocolitis; PDA, patent ductus arteriosus; RDS, respiratory distress syndrome; ROP, retinopathy of prematurity.
aNo statistically significant P value in the mild hypothermia group compared to the normothermia group.
b P value in the moderate hypothermia group compared to normothermia group.
cCo-variates included in the logistic regression included birth weight, chorioamnionitis, antenatal steroids, resuscitation, and sex.
dIn survivors examined. (Normothermia = 75, Mild hypothermia = 89, Moderate hypothermia = 132).
Long-term outcomes between groups.
| Normothermia no./total no. (%) | Mild hypothermia | Moderate hypothermia no./total no. (%) |
| Adjusted | ||
|---|---|---|---|---|---|---|
| OR (95% CI) | P value | |||||
| Seizure disorder | 2/62 (3.2) | 3/74 (4.1) | 6/118 (5.1) | 0.72 | 1.19 (0.27–5.17) | 0.59 |
| BSID-II MDI < 70 | 8/61 (13.1) | 10/73 (13.7) | 19/118 (16.1) | 0.55 | 1.28 (0.46–3.50) | 0.41 |
| BSID-II PDI < 70 | 12/61 (19.7) | 13/73 (17.8) | 38/118 (32.2) | 0.06 | 0.93 (0.38–2.26) | 0.15 |
| Bilateral blindness | 1/62 (1.6) | 1/74 (1.4) | 0/118 (0) | 0.35 | 0.81(0.13–4.92) | 0.20 |
| Hearing impairment | 1/62 (1.6) | 0/74 (0) | 2/118 (1.6) | 1.00 | 0.61 (0.04–2.71) | 0.14 |
| Moderate to severe cerebral palsy | 6/62 (9.7) | 7/74 (9.5) | 13/118 (11.2) | 0.74 | 0.98 (0.31–3.04) | 0.96 |
| NDI | 15/62 (24.2) | 18/74 (24.3) | 41/118 (34.7) | 0.12 | 1.08(0.48–2.45) | 0.23 |
| Death or NDI | 19/66 (28.8) | 29/85 (34.1) | 71/148 (48.0) | 0.006 | 1.32 (0.60–2.77) | 0.16 |
BSID-II, Bayley Scales of Infant Development, Second Edition; MDI, Mental Development Index; NDI, neurodevelopment impairment; PDI, Psychomotor Development Index.
aNo statistically significant P value in the mild hypothermia group compared to the normothermia group.
b P value in the moderate hypothermia group compared to the normothermia group.
cCo-variates included in the logistic regression included birth weight, chorioamnionitis, antenatal steroids, maternal education level, resuscitation, and sex.
dNDI is defined as any of the following: MDI < 70, PDI < 70, blindness, hearing impairment, or cerebral palsy.
eData for this outcome only exclude infants who were lost to follow-up.